Projects

Research

Defining target penicillin concentrations for subsequent studies of a reformulated long-acting benzathine penicillin prototype

Jonathan Tim Carapetis AM Barnett AM MBBS FRACP FAFPHM PhD FAHMS PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Head of the Strep A Pathogenesis & Diagnostics team, Deputy Head of the Wesfarmers Centre of Vaccines and

Research

Defining Group A Streptococcus interaction with the tonsil epithelium to inform vaccine development

Anthony Jonathan Tim Kicic Carapetis AM Barnett BSc (Hons) PhD AM MBBS FRACP FAFPHM PhD FAHMS PhD Rothwell Family Fellow; Head, Airway Epithelial Research Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Head of the Strep A

Research

Controlled Human Infection for Penicillin Against Streptococcus pyogenes – a double blinded randomised trail (The CHIPS trial)

Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@thekids.org.au Institute Director; Head, Strep A Translation; Co-Founder of REACH Professor Carapetis is

Research

Coalition to Advance Vaccines Against Group A Streptococcus (CANVAS): A Trans-Tasman Initiative Against Rheumatic Fever

Investigators: Amy Baker, Jeffrey Cannon, Jonathan Carapetis, Katherine Gray, Yue Wu External collaborators: University of Auckland: Nikki Moreland, John Fraser, Diana Lennon Otago University: Michael Baker Griffith University: Michael Good, Michael

Research

Burden of rheumatic heart disease (RHD) and impact of prevention strategies: comprehensive evidence to drive the RHD Endgame

Jonathan Judy Rosemary Carapetis AM Katzenellenbogen Wyber AM MBBS FRACP FAFPHM PhD FAHMS BSc (Occ Ther) BSc Hons (Epidemiol) MSc PhD MBChB MPH FRACGP PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Honorary Research